Literature DB >> 16254128

Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain.

O O Ogunshola1, V Djonov, R Staudt, J Vogel, M Gassmann.   

Abstract

Excessive erythrocytosis results in severely increased blood viscosity, which may have significant detrimental effects on endothelial cells and, ultimately, function of the vascular endothelium. Because blood-brain barrier stability is crucial for normal physiological function, we used our previously characterized erythropoietin-overexpressing transgenic (tg6) mouse line (which has a hematocrit of 0.8-0.9) to investigate the effect of excessive erythrocytosis on vessel number, structure, and integrity in vivo. These mice have abnormally high levels of nitric oxide (NO), a potent proinflammatory molecule, suggesting altered vascular permeability and function. In this study, we observed that brain vessel density of tg6 mice was significantly reduced (16%) and vessel diameter was significantly increased (15%) compared with wild-type mice. Although no significant increases in vascular permeability under normoxic or acute hypoxic conditions (8% O2 for 4 h) were detected, electron-microscopic analysis revealed altered morphological characteristics of the tg6 endothelium. Tg6 brain vascular endothelial cells appeared to be activated, with increased luminal protrusions reminiscent of ongoing inflammatory processes. Consistent with this observation, we detected increased levels of intercellular adhesion molecule-1 and von Willebrand factor, markers of endothelial activation and damage, in brain tissue. We propose that chronic excessive erythrocytosis and sustained high hematocrit cause endothelial damage, which may, ultimately, increase susceptibility to vascular disease.

Entities:  

Mesh:

Year:  2005        PMID: 16254128     DOI: 10.1152/ajpregu.00246.2005

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents.

Authors:  Boyeon Lee; Douglas Clarke; Abraham Al Ahmad; Michael Kahle; Christi Parham; Lisa Auckland; Courtney Shaw; Mehmet Fidanboylu; Anthony Wayne Orr; Omolara Ogunshola; Andrzej Fertala; Sarah A Thomas; Gregory J Bix
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

2.  Excessive erythrocytosis compromises the blood-endothelium interface in erythropoietin-overexpressing mice.

Authors:  Vincent Richter; Michele D Savery; Max Gassmann; Oliver Baum; Edward R Damiano; Axel R Pries
Journal:  J Physiol       Date:  2011-08-22       Impact factor: 5.182

3.  Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo.

Authors:  Tiziana Mennini; Massimiliano De Paola; Paolo Bigini; Cristina Mastrotto; Elena Fumagalli; Sara Barbera; Manuela Mengozzi; Barbara Viviani; Emanuela Corsini; Marina Marinovich; Lars Torup; Johan Van Beek; Marcel Leist; Michael Brines; Antony Cerami; Pietro Ghezzi
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

4.  Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin.

Authors:  Domenico Ribatti; Enrico Crivellato; Beatrice Nico; Diego Guidolin; Max Gassmann; Valentin Djonov
Journal:  J Anat       Date:  2009-08-18       Impact factor: 2.610

Review 5.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

6.  Prevalence, clinical profile, iron status, and subject-specific traits for excessive erythrocytosis in andean adults living permanently at 3,825 meters above sea level.

Authors:  Aldo De Ferrari; J Jaime Miranda; Robert H Gilman; Victor G Dávila-Román; Fabiola León-Velarde; Maria Rivera-Ch; Luis Huicho; Antonio Bernabé-Ortiz; Robert A Wise; William Checkley
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

7.  Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.

Authors:  M Moransard; M Bednar; K Frei; M Gassmann; O O Ogunshola
Journal:  J Neuroinflammation       Date:  2017-10-13       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.